Delivered in part before the Section of Medicine of the Massachusetts Medical Society, June 6, 1933. Original work reported in this paper, supported in part by a grant from the Carnegie ...

Fetal growth restriction (FGR) is defined as a pathological in utero growth disorder primarily caused by factors related to ...

Bergenstal, D. M., Lipsett, M. B., Moy, R. H., and Hertz, R. (personal communication submitted for publication). Bleiberg, M. J., Ph.D. thesis, University of Virginia ...

Foscenvivint is under clinical development by Eisai and currently in Phase I for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase I drugs for Adrenocortical Carcinoma ...

Pembrolizumab is under clinical development by Merck and currently in Phase II for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase II drugs for Adrenocortical ...

Chance, B., Cohen, P., Jobsis, F., and Schoener, B., Science, 136, 325 (1962).

Glucocorticoids (GCs) show prominent circadian rhythms controlled by an interplay of clocks in the suprachiasmatic nuclei and the adrenal cortex. They serve as synchronizers of other tissue clocks ...

Vasopressin has two main functions: It is responsible for regulating the amount of water present in ... They help to regulate blood pressure and also stimulate the release of aldosterone from the ...

Abstract: Sensorimotor transformations are nonlinear mappings of sensory inputs to motor responses. We explore here the possibility that the responses of single neurons in the parietal cortex serve as ...

This classification of the disease is the result of immune-mediated destruction of more than 90% of the adrenal cortex and ...